Publications

Chikungunya vaccine development, challenges, and pathway toward public health impact.

Maure, C; Khazhidinov, K; KANG, H; AUZENBERGS, M; Moyersoen, P; ABBAS, K; Santos, GM L; Medina, LM H; Wartel, TA; Kim, JH; Clemens, J; Sahastrabuddhe, S;

2024

Vaccine, (2024).42 26 10.1016/j.vaccine.2024.126483.

ManuelaQuaresma/CSI.

Rubio, FJ; QUARESMA, M; RACHET, B;

2024

, Github (2024).

The full health, economic, and social benefits of prospective Strep A vaccination.

Cadarette, D; Ferranna, M; Cannon, JW; ABBAS, K; Giannini, F; Zucker, L; Bloom, DE;

2023

npj Vaccines, (2023).8 1 10.1038/s41541-023-00758-z.

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health, (2023).11 4 10.1016/S2214-109X(23)00045-1.

Is neglect of self-clearance biassing TB vaccine impact estimates?.

SCARPONI, D; Clark, R; Weerasuriya, C; EMERY, J; HOUBEN, RM G J; WHITE, R; MCCREESH, N;

2023

medRxiv (2023). 10.1101/2023.04.11.23288400.

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment.

Rangaka, MX; Frick, M; Churchyard, G; García-Basteiro, AL; Hatherill, M; Hanekom, W; Hill, PC; Hamada, Y; Quaife, M; Vekemans, J; WHITE, RG; Cobelens, F;

2023

The Lancet. Respiratory medicine, (2023).11 4 10.1016/s2213-2600(23)00084-x.

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer.

SCARPONI, D; Iskauskas, A; CLARK, RA; Vernon, I; McKinley, TJ; Goldstein, M; Mukandavire, C; Deol, A; Weerasuriya, C; Bakker, R; WHITE, RG; MCCREESH, N;

2023

Epidemics, (2023).43, 10.1016/j.epidem.2023.100678.

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.

OpenSAFELY Collaborative,; PARKER, EP; TAZARE, J; Hulme, WJ; Bates, C; Carr, EJ; Cockburn, J; Curtis, HJ; Fisher, L; Green, AC; Harper, S; Hester, F; Horne, EM; Loud, F; Lyon, S; MAHALINGASIVAM, V; Mehrkar, A; Nab, L; Parry, J; Santhakumaran, S; Steenkamp, R; Sterne, JA; Walker, AJ; WILLIAMSON, EJ; Willicombe, M; ... TOMLINSON, LA.

2023

BMJ Open, (2023).13 1 10.1136/bmjopen-2022-066164.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Clark, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking.

GRAHAM, S; Tessier, E; Stowe, J; Bernal, JL; PARKER, EP K; NITSCH, D; MILLER, E; Andrews, N; Walker, JL; McDonald, HI;

2023

Nature communications, (2023).14 1 10.1038/s41467-023-39674-0.